Ang Luo
State Key Laboratory Of Respiratory Disease
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Omaveloxolone Driven NRF2 Activation as a Novel Therapeutic Strategy for Pulmonary Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: July 27, 2026
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
Journal: Circulation
Published: May 02, 2024
Proteomic and Phosphoproteomic Analysis of Right Ventricular Hypertrophy in the Pulmonary Hypertension Rat Model.
Journal: Journal of proteome research
Published: November 28, 2023
Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model.
Journal: International journal of molecular sciences
Published: April 19, 2023
SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy.
Journal: Signal transduction and targeted therapy
Published: August 16, 2022
Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension.
Journal: Frontiers in pharmacology
Published: August 15, 2021
Artemisinin Improves Acetylcholine-Induced Vasodilatation in Rats with Primary Hypertension.
Journal: Drug design, development and therapy
Published: July 27, 2021
Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
Journal: Oxidative medicine and cellular longevity
Published: May 27, 2021
Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial Hypertension.
Journal: Frontiers in cell and developmental biology
Published: April 27, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026